You are here

Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2.

TitleAbsence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2.
Publication TypeJournal Article
Year of Publication2009
AuthorsNairz, M, Theurl, I, Schroll, A, Theurl, M, Fritsche, G, Lindner, E, Seifert, M, Crouch, M-LV, Hantke, K, Akira, S, Fang, FC, Weiss, G
JournalBlood
Volume114
Issue17
Pagination3642-51
Date Published2009 Oct 22
ISSN1528-0020
KeywordsAcute-Phase Proteins, Animals, Bacterial Proteins, Cells, Cultured, Cytokines, Disease Models, Animal, Female, Gene Expression Regulation, Bacterial, Histocompatibility Antigens Class I, Iron, Lipocalins, Macrophages, Male, Membrane Proteins, Mice, Mice, Inbred C57BL, Mice, Knockout, Nitrites, Oncogene Proteins, Reactive Oxygen Species, Salmonella Infections, Animal, Salmonella typhimurium
Abstract

Mutations of HFE are associated with hereditary hemochromatosis, but their influence on host susceptibility to infection is incompletely understood. We report that mice lacking one or both Hfe alleles are protected from septicemia with Salmonella Typhimurium, displaying prolonged survival and improved control of bacterial replication. This increased resistance is paralleled by an enhanced production of the enterochelin-binding peptide lipocalin-2 (Lcn2), which reduces the availability of iron for Salmonella within Hfe-deficient macrophages. Accordingly, Hfe(-/-)Lcn2(-/-) macrophages are unable to efficiently control the infection or to withhold iron from intracellular Salmonella. Correspondingly, the protection conferred by the Hfe defect is abolished in Hfe(-/-) mice infected with enterochelin-deficient Salmonella as well as in Hfe(-/-)Lcn2(-/-) mice infected with wild-type bacteria. Thus, by induction of the iron-capturing peptide Lcn2, absence of functional Hfe confers host resistance to systemic infection with Salmonella, thereby providing an evolutionary advantage which may account for the high prevalence of genetic hemochromatosis.

DOI10.1182/blood-2009-05-223354
Alternate JournalBlood
PubMed ID19700664
PubMed Central IDPMC2766679
Grant ListAI39557 / AI / NIAID NIH HHS / United States
AI54052 / AI / NIAID NIH HHS / United States